| Literature DB >> 35203999 |
Dorota Kostrzewa-Nowak1, Robert Nowak1, Joanna Kubaszewska1, Waldemar Gos2.
Abstract
Everyday life's hygiene and professional realities, especially in economically developed countries, indicate the need to modify the standards of pro-health programs as well as modern hygiene and work ergonomics programs. These observations are based on the problem of premature death caused by civilization diseases. The biological mechanisms associated with financial risk susceptibility are well described, but there is little data explaining the biological basis of neuroaccounting. Therefore, the aim of the study was to present relationships between personality traits, cognitive competences and biological factors shaping behavioral conditions in a multidisciplinary aspect. This critical review paper is an attempt to compile biological and psychological factors influencing the development of professional competences, especially decent in the area of accounting and finance. We analyzed existing literature from wide range of scientific disciplines (including economics, psychology, behavioral genetics) to create background to pursuit multidisciplinary research models in the field of neuroaccounting. This would help in pointing the best genetically based behavioral profile of future successful financial and accounting specialists.Entities:
Keywords: behavioral genetics; neuroaccounting; personality
Year: 2022 PMID: 35203999 PMCID: PMC8870650 DOI: 10.3390/brainsci12020236
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Classification of adrenergic receptors [56,57,58]. cAMP—3’,5’-cyclic adenosine monophosphate, DAG—diacylglycerol, IP3–inositol 1,4,5-trisphosphate, PKA—protein kinase A, PKC—protein kinase C, PLC—phospholipase C.
List of genes associated with human intelligence [172,173,191,192,193].
| Gene | Protein | Chromosome Localization |
|---|---|---|
|
| alcohol dehydrogenase 2 | 4q21–q23 |
|
| alcohol dehydrogenase 3 | 4q21–q23 |
|
| alcohol dehydrogenase 5 | 4q21–q25 |
|
| beta-2 adrenergic receptor | 5q33 |
|
| alanine-glyoxylate and serine-pyruvate aminotransferase | 2p36–q37 |
|
| alkaline phosphatase, placental | 2q37 |
|
| alkaline phosphatase | 1p36.1–p34 |
|
| apolipoprotein E | 19q13 |
|
| sodium-potassium ATPase subunit beta 1 | 1q22 |
|
| aldehyde dehydrogenase 5 family member A1 | 6p22 |
|
| abnormal spindle-like microcephaly-associated protein | 1q31 |
|
| brain-derived neurotrophic factor | 11p14 |
|
| bactericidal permeability-increasing | 20q12 |
|
| atrophin-1 | 12p |
|
| cholinergic receptor muscarinic 2 | 7q33 |
|
| CD27 antigen | 12p13 |
|
| cholecystokinin A receptor | 4p15 |
|
| cathepsin D | 11p15 |
|
| cholinergic receptor nicotinic alpha 7 subunit | 15q14 |
|
| cytochrome P450 family 2 subfamily D member 6 | 22q13 |
|
| catechol-O-methyltransferase | 22q11 |
|
| brain-type creatine kinase also | 14q32.3 |
|
| dystrobrevin binding protein 1 | 6p22 |
|
| disrupted-in-dchizophrenia 1 (DISC1) scaffold protein | 1q42.1 |
|
| dopamine transporter 1 | 5p15.3 |
|
| myotonic dystrophy | 19q13.3 |
|
| microcephalin 1 | 8p23 |
|
| dopamine receptor D1 | 5q34–q35 |
|
| dopamine receptor D2 | 11q23 |
|
| dopamine receptor D3 | 3q13.3 |
|
| dopamine receptor D4 | 11p15 |
|
| cDNA sequence from hippocampal library | 15926 bp mtDNA |
|
| estrogen receptor | 6q24–q27 |
|
| fatty acid desaturase 2 | 11q12 |
|
| fibrillin-1 | 15q15 |
|
| glucose transporter 2 | 3q26 1–q26.3 |
|
| glucose transporter 3 | 12p13.3 |
|
| glucose transporter 4 | 17p13 |
|
| glutamate decarboxylase 1 | 2q31.1 |
|
| acid alpha-glucosidase | 17q23 |
|
| glucocorticoid receptor | 5q31–q32 |
|
| heat shock protein | 6p21.3 |
|
| beta-hexosaminidase A | 15q23–q24 |
|
| beta-hexosaminidase B | 5q13 |
|
| Homeobox 2F | 17q21–q22 |
|
| Homeobox 2G | 17q21–q22 |
|
| serotonin-receptor 2 | 13q14–q21 |
|
| serotonin-receptor 2A | 13q14 |
|
| major histocompatibility complex, class I, H | 6p21.3 |
|
| major histocompatibility complex, class I, A | 6p21.3 |
|
| haptoglobin | 16q22.1 |
|
| insulin receptor | 19p13.3–p13.2 |
|
| insulin-like growth factor 2 receptor | 6q26 |
|
| klotho | 13q13 |
|
| laminin subunit beta 1 | 7q31 |
|
| laminin subunit beta 2 | 3p21 |
|
| myosin heavy chain 2 | 17p13.1 |
|
| microtubule associated protein 2 | 2q34–q35 |
|
| monoamine oxidase A | Xp11.3 |
|
| neutrin 1 | 6p25.1 |
|
| nerve growth factor-beta | 1p13 |
|
| neurofilament medium polypeptide | 8p21.2 |
|
| oxytocin receptor | 3p25 |
|
| ornithine carbamoyltransferase | Xp11.4 |
|
| protein phosphatase 1 regulatory subunit 1B | 17q12 |
|
| propionyl-CoA carboxylase subunit A | 13q31–q34 |
|
| propionyl-CoA carboxylase subunit B | 3q21-–q22 |
|
| phenylalanine hydroxylase | 12q22–q24.2 |
|
| prion protein | 20p13 |
|
| parathyroid hormone | 11p15.2–p15.1 |
|
| protein C inhibitor | 14q32.1 |
|
| selectin E | 1q22–q25 |
|
| superoxide dismutase 2 [Mn], mitochondrial | 6q21 |
|
| synaptosomal-associated protein 25kDa | 20p12 |
|
| S100 calcium-binding protein B | 21q22 |
|
| sodium-dependent dopamine transporter | 5p15 |
|
| tissue inhibitor of metalloproteinases 2 | 17q22–q25 |
|
| tyrosine aminotransferase | 16q22.1 |
|
| thyroglobulin | 8q24 |
|
| transforming growth factor alpha | 2p13 |
|
| tyrosine hydroxylase | 11p15.5 |
|
| thyroid hormone receptor beta | 3p24.1–p22 |
|
| thyroid peroxidase | 2p25–p24 |
|
| uracil DNA glycosylase | 12q24 |
|
| Werner syndrome ATP-dependent helicase | 8p12 |
|
| vitamin D receptor | 12q12–q14 |
|
| Human Immunodeficiency Virus Type I Enhancer Binding Protein 1 | 6p24.1 |